Physician profile
Michael David Charles
NPI 1689096786
$10,093.39
in general payments reported to CMS, 2019-2025
13 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,378 · 2020: $3,675 · 2021: $470 · 2022: $117 · 2024: $328 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $453.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $452.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $4,391.91 | 2019-2021 | |
| Wright Medical Technology, INC. | $2,666.41 | 2019 | |
| Sequoia Surgical, INC. | $2,156.98 | 2019-2020 | |
| Stryker Corporation | $440.32 | 2019-2024 | Blueprint Patient Specific Instrumentation, Aequalis Perform Reversed, Aequalis Ascend Flex |
| Amgen INC. | $125.00 | 2025 | |
| Medacta USA, INC. | $117.00 | 2022 | |
| Smith+Nephew, INC. | $95.46 | 2019-2021 | |
| Ethicon US, LLC | $18.22 | 2019 | |
| Bioventus LLC | $18.10 | 2020 | |
| Pacira Therapeutics, INC. | $17.39 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $17.20 | 2020 | |
| Pfizer INC. | $16.28 | 2020 | |
| Depuy Synthes Sales INC. | $13.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Charles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.